GO:0045760 positive regulation of action potential: Neuronal Excitability Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045760 describes any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination, typically via modulation of voltage-gated ion channels.
• Positive regulation of action potential is central to neural circuit output, as shown by acetylcholine-synthesizing T cells that relay vagus nerve signals and require action potential generation for immune regulation.
• Voltage-gated potassium channels such as KCNQ1 and KCNA5 (Kv1.5) are direct effectors whose gating and membrane trafficking tune action potential frequency.
• Neuromodulators, including serotonin acting through 5-HT2B receptors, can positively regulate raphe neuron firing and action potential output.
• Circadian and diurnal rhythms in action potential firing have been recorded in the suprachiasmatic nucleus, linking GO:0045760 to timekeeping physiology.
• Human forebrain assembloids and astroglia-to-neuron reprogramming models now allow researchers to study fast-spiking interneuron action potential regulation in vitro.
Description
GO:0045760, positive regulation of action potential, is a biological process ontology term that captures any mechanism which activates or increases the frequency, rate or extent of action potential creation, propagation or termination. Action potentials are the fundamental electrical signals by which neurons, muscle cells and some endocrine cells communicate over distance, and their positive regulation determines how information is encoded, transmitted and decoded in excitable tissues. Because the term is defined by modulation of voltage-gated ion channels, it sits at the intersection of ion channel biophysics, neuromodulation and circuit physiology. Researchers study GO:0045760 to understand how the nervous system dynamically adjusts excitability, how peripheral neural circuits regulate immune responses, and how dysfunction of excitability contributes to neurological and psychiatric disease. The term is also practically important for drug discovery, since many therapeutic compounds act by increasing or decreasing action potential firing in specific cell types. In this article we integrate the QuickGO definition with verified PubMed literature to describe the mechanisms, key genes, disease links and experimental methods relevant to positive regulation of action potential.
positive regulation of action potential At A Glance
| GO ID | GO:0045760 |
|---|---|
| GO term | positive regulation of action potential |
| Ontology | biological_process |
| Synonym | activation of action potential; stimulation of action potential; up regulation of action potential; up-regulation of action potential; upregulation of action potential |
| Major function | Increases the frequency, rate or extent of action potential creation, propagation or termination, typically by modulating voltage-gated ion channels |
| Related cellular entities | Voltage-gated sodium, potassium and calcium channels; membrane lipid microenvironment; neuromodulatory receptors |
| Example physiological context | Vagus nerve circuit regulation of immune responses via acetylcholine-synthesizing T cells |
| Example molecular regulator | KCNQ1 gating by membrane electric field and PIP2 binding; Kv1.5 (KCNA5) sensitivity to SGK3 |
| Disease relevance | Schizophrenia-associated defects in fast-spiking PVALB+ interneurons; serotonin 2B receptor modulation of raphe firing |
What Is GO:0045760?
According to the QuickGO definition, positive regulation of action potential (GO:0045760) refers to any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination. This regulation typically occurs via modulation of the activity or expression of voltage-gated ion channels. In other words, the term covers molecular and cellular events that make excitable cells more likely to fire, fire more often, conduct action potentials more reliably, or terminate them in a controlled manner. It is a biological process term and includes mechanisms such as altered channel gating, changes in channel surface expression, neuromodulatory signaling, and changes in the electrical properties of the membrane.
Why Is positive regulation of action potential Important in Cell Biology?
Positive regulation of action potential is important because it determines the output of excitable cells and thus controls processes as diverse as sensory coding, motor command, circadian timing, autonomic control and neuroimmune communication. Because the term is defined by modulation of voltage-gated ion channels, it provides a mechanistic framework for understanding how neurotransmitters, second messengers and membrane lipids tune excitability. In disease, altered positive regulation of action potential contributes to psychiatric disorders such as schizophrenia, where fast-spiking interneuron function is impaired, and to disorders of serotonin signaling that affect mood and raphe neuron activity. The term is also a practical target for experimental cell models, because CRISPR-based knockout, point mutation, knock-in and overexpression of ion channel and receptor genes allow researchers to test causal roles in action potential regulation.
• Defines how excitable cells increase firing frequency and reliability, which is essential for neural coding and circuit output.
• Provides a mechanistic link between voltage-gated ion channel gating and physiological excitability.
• Underlies neuromodulatory control of behavior and physiology, including serotonin 2B receptor positive regulation of raphe neurons.
• Is relevant to neuroimmune circuits, where acetylcholine-synthesizing T cells relay vagus nerve signals and require action potential generation.
• Contributes to circadian and diurnal rhythms through action potential firing rhythms in the suprachiasmatic nucleus.
• Is implicated in schizophrenia-associated defects in fast-spiking human PVALB+ cortical interneurons.
• Can be studied in human forebrain assembloids that support development of fast-spiking interneurons.
• Can be modeled by reprogramming astroglia into neurons with fast-spiking parvalbumin-positive interneuron hallmarks.
• Offers targets for pharmacological modulation, as shown by frequency-dependent neuromodulation.
• Supports development of CRISPR cell models to test causal roles of ion channel and receptor genes in excitability.
What Happens During positive regulation of action potential?
Initiation of action potential creation
In simple terms: The cell becomes more likely to start an electrical signal.
Positive regulation of action potential begins with processes that increase the probability or rate of action potential creation. This typically involves modulation of voltage-gated ion channels that set the resting membrane potential and threshold, such as potassium channels whose gating properties determine excitability. For example, the membrane electric field regulates the PIP2-binding site to gate the KCNQ1 channel, directly influencing when an action potential can be initiated. Similarly, SGK3 sensitivity of the voltage-gated K+ channel Kv1.5 (KCNA5) affects channel activity and thus the excitability of cells expressing this channel. Neuromodulators can also increase the likelihood of action potential creation, as shown by serotonin 2B receptors positively regulating raphe serotonin neurons.
Propagation and frequency modulation
In simple terms: Once started, the signal can travel more often or more reliably.
After initiation, positive regulation of action potential includes mechanisms that increase the frequency or reliability of propagation. Frequency-dependent action of neuromodulation demonstrates that the effects of neuromodulators on firing depend on the ongoing activity pattern of the neuron. In the suprachiasmatic nucleus, action potential firing rhythms are maintained with distinct temporal patterns in diurnal animals, showing that propagation and frequency are actively regulated. Voltage-gated potassium channels such as Kv1.5 and KCNQ1 shape action potential duration and afterhyperpolarization, thereby influencing how frequently a cell can fire.
Termination and afterhyperpolarization control
In simple terms: The signal is shut off in a controlled way so the cell can fire again.
Positive regulation of action potential also encompasses modulation of termination, because the rate of termination determines the refractory period and the maximum firing frequency. Voltage-gated potassium channels are central to this step; KCNQ1 gating is regulated by the membrane electric field and PIP2 binding, which affects the timing of repolarization. Kv1.5 (KCNA5) activity, which is sensitive to SGK3, also contributes to setting the duration of the action potential and the subsequent recovery period. Thus, positive regulation can occur by accelerating or delaying termination in a context-dependent manner.
Neuromodulatory and circuit-level control
In simple terms: Other cells and chemicals can turn the firing up or down.
At the circuit level, positive regulation of action potential is often driven by neuromodulators and neural inputs. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit, demonstrating that action potential generation in immune cells can be positively regulated by neural activity. Serotonin 2B receptors positively regulate raphe serotonin neurons, providing a direct example of receptor-mediated increases in firing. Frequency-dependent neuromodulation further shows that the same modulator can have different effects depending on the firing history of the neuron. These circuit-level mechanisms ensure that positive regulation is temporally and spatially specific.
Developmental and cell-type-specific regulation
In simple terms: Different cell types regulate their firing in specialized ways.
Positive regulation of action potential is cell-type specific. Human forebrain assembloids support the development of fast-spiking human PVALB+ cortical interneurons and reveal schizophrenia-associated defects, showing that action potential regulation is developmentally programmed and disease-relevant. Reprogramming astroglia into neurons with hallmarks of fast-spiking parvalbumin-positive interneurons by phospho-site-deficient Ascl1 demonstrates that action potential properties can be engineered by manipulating transcription factor phosphorylation. These studies highlight that positive regulation of action potential is not a generic property but is tuned by cell identity and developmental state.
Key Genes Involved in GO:0045760 positive regulation of action potential
The following genes and proteins are experimentally implicated in positive regulation of action potential, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNQ1 | Voltage-gated potassium channel; gating regulated by membrane electric field and PIP2 binding | Directly controls action potential initiation and termination; studied by electrophysiology and mutagenesis |
| KCNA5 (Kv1.5) | Voltage-gated potassium channel; sensitive to SGK3 | Modulates action potential duration and firing frequency; target for kinase signaling studies |
| HTR2B (5-HT2B receptor) | Serotonin receptor that positively regulates raphe serotonin neurons | Links neuromodulation to increased action potential firing; studied in raphe circuits |
| ASCL1 | Transcription factor; phospho-site-deficient form reprograms astroglia into fast-spiking neurons | Used to engineer neurons with fast-spiking parvalbumin-positive interneuron hallmarks |
| PVALB | Parvalbumin, a calcium-binding protein marking fast-spiking interneurons | Marker of fast-spiking human cortical interneurons in forebrain assembloids |
| SLC18A3 (VAChT) | Vesicular acetylcholine transporter; involved in acetylcholine synthesis and packaging | Relevant to acetylcholine-synthesizing T cells that relay vagus nerve signals |
| CHAT | Choline acetyltransferase; synthesizes acetylcholine | Required for acetylcholine production in T cells that relay neural signals |
| SCN firing machinery (multiple channels) | Suprachiasmatic nucleus action potential firing rhythms | Used to study diurnal regulation of action potential frequency |
| SGK3 | Serum- and glucocorticoid-regulated kinase 3; modulates Kv1.5 | Kinase that influences voltage-gated K+ channel activity and excitability |
| PIP2 | Membrane phospholipid that binds and regulates KCNQ1 | Lipid regulator of channel gating and action potential termination |
| Voltage-gated Na+ channels (generic) | Generate the upstroke of the action potential | Core effectors of action potential creation; modulated in positive regulation |
| Voltage-gated Ca2+ channels (generic) | Contribute to depolarization and neurotransmitter release | Modulated in circuits that positively regulate firing |
| 5-HT (serotonin) | Neurotransmitter acting on 5-HT2B receptors | Neuromodulator that positively regulates raphe neuron firing |
| Acetylcholine | Neurotransmitter in vagus nerve circuits | Relays neural signals and supports action potential generation in T cells |
| Ascl1 phospho-mutants | Engineered transcription factor variants | Used to reprogram astroglia into fast-spiking neurons |
| Human PVALB+ interneurons | Fast-spiking cortical interneurons | Model for schizophrenia-associated defects in action potential regulation |
How Is positive regulation of action potential Regulated?
Positive regulation of action potential is itself regulated at multiple levels. At the channel level, the membrane electric field regulates the PIP2-binding site to gate the KCNQ1 channel, meaning that changes in membrane potential directly feed back on channel activity and action potential termination. Kinase signaling also regulates excitability: SGK3 sensitivity of the voltage-gated K+ channel Kv1.5 (KCNA5) shows that phosphorylation-dependent pathways can tune channel function and thus action potential frequency. At the receptor level, serotonin 2B receptors positively regulate raphe serotonin neurons, providing a neuromodulatory input that increases firing. Neuromodulation can be frequency-dependent, so the history of action potential firing determines how a modulator will affect subsequent activity. Finally, developmental and transcriptional programs regulate the expression of ion channels and calcium-binding proteins, as shown by reprogramming astroglia into fast-spiking parvalbumin-positive interneurons with phospho-site-deficient Ascl1 and by the development of fast-spiking human PVALB+ interneurons in forebrain assembloids.
positive regulation of action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PVALB | Schizophrenia-associated defects in fast-spiking cortical interneurons | Human forebrain assembloids with PVALB+ interneurons |
| HTR2B | Serotonin signaling and raphe neuron excitability in mood disorders | Raphe neuron cultures or in vivo models with receptor modulation |
| CHAT / SLC18A3 | Neuroimmune vagus nerve circuit dysfunction | Acetylcholine-synthesizing T cell models and vagus nerve circuit assays |
| KCNQ1 | Channel gating disorders affecting action potential termination | Heterologous expression with electrophysiology and PIP2 manipulation |
| KCNA5 (Kv1.5) | Excitability disorders linked to kinase signaling | Cell lines expressing Kv1.5 with SGK3 modulation |
Schizophrenia and fast-spiking interneuron dysfunction
Schizophrenia is associated with defects in fast-spiking human PVALB+ cortical interneurons. Forebrain assembloids that support the development of these interneurons have uncovered schizophrenia-associated defects, linking positive regulation of action potential in PVALB+ cells to disease mechanisms. Because fast-spiking interneurons control network oscillations and information processing, impaired action potential regulation in these cells may contribute to cognitive symptoms.
Serotonin signaling and raphe neuron excitability
Serotonin 2B receptors positively regulate raphe serotonin neurons, and this regulation is relevant to mood and affective disorders. Altered positive regulation of action potential in raphe neurons could change serotonin release and contribute to psychiatric conditions. Frequency-dependent neuromodulation further suggests that disease-related changes in firing history may alter how serotonin and other modulators affect circuit output.
Neuroimmune and autonomic circuit dysfunction
Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit, and action potential generation in these cells is required for the circuit to function. Dysregulation of this neuroimmune interface could affect inflammatory responses and autonomic control. Positive regulation of action potential in immune cells is therefore a potential mechanism linking neural activity to immune function.
Circadian rhythm and sleep disorders
Action potential firing rhythms in the suprachiasmatic nucleus are essential for circadian timekeeping, and these rhythms differ between diurnal and nocturnal species. Disruption of positive regulation of action potential in clock neurons could contribute to circadian rhythm and sleep disorders. Studying these rhythms provides a physiological context for understanding how firing frequency is positively regulated over the day.
From positive regulation of action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a voltage-gated potassium channel increase action potential frequency? | Knockout cell model (e.g., KCNQ1 or KCNA5 KO) with electrophysiology |
| Does a specific channel phosphorylation site control action potential termination? | Point-mutation knock-in of the phospho-site in the channel gene |
| Can a transcription factor variant reprogram glia into fast-spiking neurons? | Knock-in or overexpression of phospho-site-deficient Ascl1 in astroglia |
| Can a receptor be tagged to track its role in raphe neuron firing? | Tagged knock-in of HTR2B in serotonin neurons |
| Does overexpression of a calcium-binding protein alter fast-spiking properties? | Overexpression of PVALB in human interneuron models |
| Can neural input to immune cells be dissected genetically? | Knockout of ChAT or SLC18A3 in T cells within vagus nerve circuit models |
How to Study the positive regulation of action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Action potential threshold, frequency, duration and termination | Testing channel mutations or neuromodulators |
| Extracellular recording | Firing rate and rhythm in circuits | Suprachiasmatic nucleus firing rhythms |
| Channel gating assays | Voltage dependence and PIP2 sensitivity | KCNQ1 gating studies |
| Kinase co-expression assays | Effect of kinases on channel activity | SGK3 sensitivity of Kv1.5 |
| Neuromodulator application | Change in firing frequency | Serotonin 2B receptor regulation of raphe neurons |
| Vagus nerve circuit assays | Action potential-dependent immune signaling | Acetylcholine-synthesizing T cell studies |
| Human forebrain assembloids | Development and function of fast-spiking interneurons | Schizophrenia-associated defect modeling |
| Astroglia reprogramming | Acquisition of fast-spiking neuron hallmarks | Ascl1 phospho-mutant studies |
Electrophysiology and action potential recordings
Patch-clamp and extracellular recording are the primary methods for measuring positive regulation of action potential. They allow direct measurement of firing frequency, threshold, duration and termination, and are used to test how channel mutations or neuromodulators alter excitability. In the suprachiasmatic nucleus, long-term recordings reveal action potential firing rhythms across the day.
Ion channel gating and lipid interaction assays
Because GO:0045760 typically occurs via modulation of voltage-gated ion channels, assays that measure channel gating and lipid interactions are essential. The membrane electric field regulation of the PIP2-binding site in KCNQ1 was dissected using such approaches, revealing how membrane potential and lipid binding converge to control gating. Kinase sensitivity of Kv1.5 to SGK3 can be studied with co-expression and electrophysiology.
Circuit and neuromodulation studies
Neuromodulation experiments test how neurotransmitters and receptor agonists change action potential firing. Serotonin 2B receptor positive regulation of raphe neurons was demonstrated with such approaches, and frequency-dependent neuromodulation requires protocols that vary the history of firing. Vagus nerve circuit studies combine neural stimulation with immune cell readouts to show action potential-dependent effects.
Human cell models and assembloids
Human forebrain assembloids support the development of fast-spiking human PVALB+ cortical interneurons and allow researchers to study schizophrenia-associated defects in action potential regulation. Reprogramming astroglia into neurons with fast-spiking parvalbumin-positive interneuron hallmarks provides another human-relevant model for testing causal genes.
How CRISPR Can Be Used to Study GO:0045760 positive regulation of action potential
Knockout
CRISPR knockout of voltage-gated ion channel genes such as KCNQ1 or KCNA5 can test whether loss of channel function increases or decreases action potential frequency and termination. Knockout of ChAT or SLC18A3 in immune cells can test the requirement for acetylcholine synthesis in vagus nerve circuit action potential-dependent signaling. Knockout models are essential for establishing causality in positive regulation of action potential.
Point Mutation
Point mutation knock-in can dissect specific residues that control channel gating or kinase sensitivity. For example, mutating the SGK3-sensitive site in Kv1.5 (KCNA5) would test its role in action potential regulation. Similarly, phospho-site mutations in Ascl1 have been used to reprogram astroglia into fast-spiking neurons, showing that single phosphorylation sites can control neuronal excitability programs.
Knock-in
Knock-in of tags or reporters into genes such as HTR2B or PVALB allows researchers to track receptor localization and interneuron identity while measuring action potential regulation. Knock-in of disease-associated variants into human cell models can reveal how specific mutations alter fast-spiking interneuron function.
Overexpression
Overexpression of ion channels, receptors or calcium-binding proteins can test sufficiency for positive regulation of action potential. Overexpressing PVALB in human interneuron models can probe its role in fast-spiking properties, while overexpression of phospho-site-deficient Ascl1 drives astroglia-to-neuron reprogramming with fast-spiking hallmarks. Overexpression of SGK3 or its mutants can test kinase-dependent regulation of Kv1.5.
How EDITGENE Supports positive regulation of action potential Research
Researchers studying positive regulation of action potential-related genes often need to determine whether a candidate gene is causally involved in setting firing frequency, propagation or termination. EDITGENE provides CRISPR-based cell models and screening services that allow precise manipulation of ion channel, receptor and transcription factor genes in relevant cell types, enabling functional tests of action potential regulation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of action potential research.
Frequently Asked Questions About positive regulation of action potential
What is GO:0045760 positive regulation of action potential?
GO:0045760 is a biological process term describing any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination, typically via modulation of voltage-gated ion channels.
What genes are involved in positive regulation of action potential?
Genes include voltage-gated potassium channels such as KCNQ1 and KCNA5 (Kv1.5), the serotonin receptor HTR2B, the transcription factor ASCL1, and the calcium-binding protein PVALB.
How is positive regulation of action potential studied experimentally?
Researchers use patch-clamp electrophysiology, extracellular recording, channel gating assays, neuromodulator application and human forebrain assembloids to measure changes in firing frequency and termination.
What is the role of KCNQ1 in action potential regulation?
KCNQ1 is a voltage-gated potassium channel whose gating is regulated by the membrane electric field and PIP2 binding, directly influencing action potential initiation and termination.
How does serotonin regulate action potential firing?
Serotonin 2B receptors positively regulate raphe serotonin neurons, increasing their firing and providing a neuromodulatory mechanism for positive regulation of action potential.
Can CRISPR be used to study positive regulation of action potential?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of ion channel, receptor and transcription factor genes in action potential regulation.
What diseases are linked to abnormal action potential regulation?
Schizophrenia has been linked to defects in fast-spiking PVALB+ interneurons, and serotonin signaling disorders involve altered raphe neuron firing.
What is the role of PVALB in fast-spiking interneurons?
PVALB is a calcium-binding protein that marks fast-spiking interneurons; human forebrain assembloids support the development of PVALB+ interneurons and reveal schizophrenia-associated defects.
How does neuromodulation affect action potential frequency?
Neuromodulation can be frequency-dependent, meaning the effect of a modulator on firing depends on the neuron's prior activity history.
What cell models are available for studying action potential regulation?
Models include heterologous cells expressing specific channels, raphe neuron cultures, human forebrain assembloids, and astroglia reprogrammed into fast-spiking neurons.
Conclusion
GO:0045760 positive regulation of action potential is a central biological process that governs how excitable cells increase their firing frequency, propagation reliability and termination control. The term is mechanistically anchored in voltage-gated ion channel modulation, as illustrated by KCNQ1 gating and Kv1.5 regulation, and is physiologically important in neural circuits ranging from the vagus nerve to the suprachiasmatic nucleus. Disease links include schizophrenia-associated defects in fast-spiking PVALB+ interneurons and serotonin signaling disorders affecting raphe neurons. With CRISPR-based knockout, point mutation, knock-in and overexpression models, researchers can now test causal roles of specific genes in positive regulation of action potential and translate these findings into therapeutic hypotheses.
References
- 1. Rosas-Ballina M et al.. 2011. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit.. Science 334(6052):98-101 PMID: 21921156
- 2. Marichal N et al.. 2024. Reprogramming astroglia into neurons with hallmarks of fast-spiking parvalbumin-positive interneurons by phospho-site-deficient Ascl1.. Sci Adv 10(43):eadl5935 PMID: 39454007
- 3. Morioka E et al.. 2023. Action potential firing rhythms in the suprachiasmatic nucleus of the diurnal grass rat, Arvicanthis niloticus.. Neurosci Lett 792:136954 PMID: 36347340
- 4. Walsh RM et al.. 2025. Forebrain assembloids support the development of fast-spiking human PVALB+ cortical interneurons and uncover schizophrenia-associated defects.. Neuron 113(19):3185-3203.e7 PMID: 40695284
- 5. Schneider AC et al.. 2021. Frequency-Dependent Action of Neuromodulation.. eNeuro 8(6) PMID: 34593519
- 6. Belmer A et al.. 2018. Positive regulation of raphe serotonin neurons by serotonin 2B receptors.. Neuropsychopharmacology 43(7):1623-1632 PMID: 29453444
- 7. Mandala VS et al.. 2023. The membrane electric field regulates the PIP(2)-binding site to gate the KCNQ1 channel.. Proc Natl Acad Sci U S A 120(21):e2301985120 PMID: 37192161
- 8. Ahmed M et al.. 2016. SGK3 Sensitivity of Voltage Gated K+ Channel Kv1.5 (KCNA5).. Cell Physiol Biochem 38(1):359-67 PMID: 26824455
